-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

906. Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders: Poster II

Symposia: Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Annalynn M Williams, PhD1, Karolina Breit, MS1*, Nicholas Steve Phillips, MD, PhD2*, Matthew J. Ehrhardt, MD3, Daniel A. Mulrooney, MD, MS4, Deokumar Srivastava5*, Yutaka Yasui3*, Tara Brinkman2*, Brian Potter, PhD2*, Noah Sabin2*, Belinda Mandrell2*, Kirsten K Ness, PT, PhD6*, Melissa M. Hudson, MD7 and Kevin R. Krull, PhD8*

1University of Rochester, Rochester, NY
2St. Jude Children's Research Hospital, Memphis, TN
3St. Jude Children's Research Hospital, Department of Epidemiology and Cancer Control, Memphis, TN
4St Jude Children's Research Hospital, Inc., Memphis, TN
5St. Jude Children's Research Hospital, Memphis
6Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN
7St. Jude Children's Hospital, Memphis, TN
8Department of Psychology and Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, TN

Aman Wadhwa, MD1, Benjamin Grey Vandeberg, MS2*, Qingrui Meng, MS3*, Lindsey Hageman, MPH1*, Alysia Bosworth, BA4*, Lucia Juarez, PhD2*, Ariann Nassel, MA5*, Elizabeth Baker, PhD6*, Gabriela Oates, PhD7*, Wendy Landier, PhD3*, Elizabeth Ross8*, Sarah Palmer, MA1*, Nora Balas, PhD1*, Liton Francisco1*, Ravi Bhatia, MD9, Daniel Weisdorf, MD10, Saro Armenian, DO, MPH4 and Smita Bhatia, MD, MPH1

1Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
2Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL
3University of Alabama At Birmingham, Birmingham, AL
4City of Hope National Medical Center, Duarte, CA
5School of Public Health, University of Alabama at Birmingham, Birmingham, AL
6Department of Sociology, University of Alabama at Birmingham, Birmingham, AL
7Division of Pulmonary, Allergy and Critical Care, University of Alabama at Birmingham, Birmingham, AL
8University of Alabama at Birmingham, Birmingham, AL
9Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL
10University of Minnesota, Minneapolis, MN

Karen Costello, MSS, LSW, OSW-C*, Sally Werner, RN, BSN, MSHA*, Rylan Sweitzer, BS*, Joelys Gonzales Bisono, BSW* and Claire Saxton, MBA*

Cancer Support Community, Washington, DC

Nikhil Vojjala, MD, MBBS1, Lakshmi Vaishnavi Kattamuri2*, Sai Brigisha Kyasa, MBBS3*, Aditi Sharma, MD4 and Vijendra Singh5

1Internal Medicine, Trinity Health Oakland/Wayne State University School of Medicine, Pontiac, MI
2Texas Tech University Health Sciences, El Paso, El Paso, TX
3Internal Medicine, Kamineni Medical College, Hyderabad, Telangana, India
4Karmanos Cancer Institute/Wayne State University, Detroit, MI
5Karmanos Cancer Institute/Wayne State University/Department of Hematology-Oncology, Detroit, MI

Monica Labrano Elias1*, Seisha Von Glasenapp, Md1, Carlos Chiattone, MD, PhD2, Sergio Augusto B Brasil, MD, PhD2*, Brady Beltran, MD3,4*, Denisse Castro, MD3, Sally Paredes, MD3*, Ana Carolina Oliver, MD5, Victoria Irigoin, MD6*, Sabrina Ranero Ferrari, MD6*, Virginia Lema Spinelli7*, Carla Ambrosoni8*, Gimena Dos Santos, MD7*, Marta Elisa Zerga, MD9*, Sofía Gabriela Rivarola, MD10*, German R. Stemmelin Sr., MD10*, Fernando Warley, MSc, MD11*, Fabiola Valvert, MD, FRCP12, Julio D Fernández Águila, MD13*, Rosa Oliday14*, Macarena Roa, MD15*, Camila Peña, MD15, Javier Melo15*, Maria Lucia Fonseca Bolanos16*, Luis Mario Villela Martinez, MD, MSc17*, Arianna Robles Rodriguez18*, Juan Francisco Zazueta Pozos, MD19*, Gerardo Santigo Jimenez19*, Alonso Hernandez19*, Marialejandra Torres Viera, MD20*, Marcos Hernandez21*, Henry Quintero, MD22,23*, Jose Marcial Macias Abasto24*, Maria Panozo, MD25*, Bryan Valcarcel, MD, MPH26 and Luis Enrique Malpica Castillo, MD27

1Departamento de Hematología, Hospital Central Instituto de Previsión Social, Asunción, Paraguay
2Santa Casa Medical School of Sao Paulo, Sao Paulo, Brazil
3Hospital Edgardo Rebagliati Martins, Lima, Peru
4Instituto de Ciencias Biomedicas, Universidad Ricardo Palma, Lima, Peru
5Hematology Department, Hospital Britanico, CASMU, Montevideo, Uruguay
6Hospital de Clinicas, Montevideo, Uruguay
7Hospital Militar, Montevideo, Uruguay
8Bone marrow transplant unit, Hospital Maciel, Montevideo, Uruguay
9Angel Roffo Institute, Buenos Aires, Argentina
10Hospital Británico, Buenos Aires, Argentina
11Italian Hospital, Buenos Aires, Argentina
12INCAN, Ciudad de Guatemala, Guatemala
13Hospital Universitario Dr Gustavo Alderegia Lima, Cienfugos, Cuba
14Hospital Militar Dr. Luis Diaz Soto, Havanna, Cuba
15Hospital Del Salvador, Santiago, Chile
16Instituto Jalisciense de Cancerologia, Guadalajara, Mexico
17Hospital Fernando Ocaranza, Hermosillo, Mexico
18Hematology, Hospital General de Occidente, Cdmx, MEX
19Hospital General de Mexico Eduardo Liceaga, Ciudad de Mexico, Mexico
20Unidad Linfomas, Instituto Hematología y Oncología Universidad Central Venezuela, Caracas, Venezuela (Bolivarian Republic of)
21Metropolitano del norte universidad de Carabobo, Caracas, VEN
22Clinica Central del Eje, Pereira, Colombia
23Liga Colombiana Contra el Cancer, Pereira, Colombia
24Clinica Los Olivos, Cochabamba, Bolivia (Plurinational State of)
25Instituto Oncologico Oriente Boliviano, La Paz, AK, BOL
26George Washington University, Washington, DC
27Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Elif Yilmaz, MD1, Xiaoliang (Wendy) Wang, PhD2, Niquelle Brown Wadé3*, Yu-Lun Liu, PhD4*, Praveen Ramakrishnan Geethakumari, MD, MS5 and Ahmed Sawas, MD6

1Hematologic Malignancies and Cellular Therapy, University of Texas Southwestern Medical Center, Dallas, TX
2Flatiron Health, INC., New York, NY
3Flatiron Health, New York City, NY
4Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern, Dallas, TX
5Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX
6Flatiron Health Inc., New York, NY

Charmi Bhanushali1, Vaibhavi P Mukhtiar, MBBS2, Maya Gogtay, MBBS3, Mansi Mehta, MD1, Vidhi Bhanushali, MBBS4* and Kala Seetharaman, MD5*

1Saint Vincent Hospital, Worcester, Worcester, MA
2Saint Vincent Hospital, WORCESTER, MA
3Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE
4King Edward Memorial Hospital and Seth GS Medical College, Mumbai, India
5Division of Blood Disorders and Cancer Medicine, Saint Vincent Hospital, Worcester, MA

Karnika Mehrotra, BS1, Yanjun Chen, MS2*, Joshua Richman3*, Lindsey Hageman, MPH3*, Wendy Landier, PhD4*, Smita Bhatia, MD, MPH5 and Aman Wadhwa, MD3

1UAB Heersink School of Medicine, Birmingham, AL
2Institute for Cancer Outcomes and Survivorship, University of Alabama At Birmingham, Birmingham, AL
3Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
4University of Alabama At Birmingham, Birmingham, AL
5University of Alabama at Birmingham, Birmingham, AL

David Dingli, MD, PhD1, Enrico De Nigris, MSc2*, Siyang Leng, MD, MS3, Mohammed Z. H. Farooqui, DO3, Halit O. Yapici, MD, MBA, MPH4*, Ian Weimer, MS4*, Weiqi Jiao, ScM4*, Hayden W. Hyatt, PhD4*, Xuan Zhang, MD, PhD, PhD4*, Kunal Lodaya, MD4* and Mavis Obeng-Kusi, PhD, MPharm3*

1Division of Hematology, Mayo Clinic, Rochester, MN
2MSD (UK) Limited, London, United Kingdom
3Merck & Co., Inc., Rahway, NJ
4Boston Strategic Partners, Boston, MA

Andrew Park, PhD, MPH1, Selin Cooper1*, Sheila Mpima2*, Vicky Casey2*, Moulika Chatu2*, Ângela Nunes2*, Fil Manuguid2* and Alexander Liede1*

1AbbVie Inc., North Chicago, IL
2IQVIA, London, United Kingdom

Jia Yi Tan, MD1, Qi Xuan Ang, MBBS2*, Arya Mariam Roy, MD3, Nishi Shah, MBBS, MPH4, Jon E. Arnason, MD5 and Yong Hao Yeo, MBBS6*

1Department of Internal Medicine, Saint Michael's Medical Center, Newark, NJ
2Department of Internal Medicine, Sparrow Health System and Michigan State University, East Lansing, MI
3Rosewell Park Cancer Center, Buffalo, NY
4Hematology/Oncology, Montefiore Medical Center/ Albert Einstein College of Medicine, Bronx, NY
5Beth Israel Deaconess Medical Center, Boston, MA
6Department of Internal Medicine/Pediatrics, Corewell Health, Royal Oak, MI

James Fan Wu, MD1, Frances Dominique V. Ho2*, Erin Jay G. Feliciano, MD3,4*, Urvish Jain5*, Aryan Sekolar6*, Bhav Jain7*, Rod Carlo Columbres8,9*, Nishwant Swami10* and Edward Christopher Dee, MD11*

1Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
2College of Medicine, University of the Philippines, Manila, Philippines
3Department of Medicine, NYC Health + Hospitals/Elmhurst, Icahn School of Medicine, Queens, NY
4School of Medicine and Public Health, Ateneo de Manila University, Pasig City, Philippines
5Department of Computational & Systems Biology, University of Pittsburgh, Pittsburgh, PA
6University of California San Diego, La Jolla, CA
7Stanford School of Medicine, Palo Alto, CA
8Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
9College of Osteopathic Medicine, William Carey University, Hattiesburg, MS
10Division of Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
11Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY

Ayobami Olafimihan, MBBS1, Olanipekun Lanny Ntukidem, MD2, Praise Fawehinmi3*, Abdultawab Shaka4* and Hafeez Shaka, MD5*

1John H. Stroger Jr. Hospital of Cook County, Chicago, IL
2Trinity Health Ann Arbor, Ypsilanti, MI
3Southern Illinois University Edwardsville, Edwardsville
4Windsor University School of Medicine, Chicago
5John H. Stroger Hospital of Cook County, Chicago, IL

Jun Yang Jiang, MD1*, Trung Minh Nguyen, MD2*, Jason Lu, MD1*, Danielle Guffey, MS3*, Rockbum Kim, MD, PhD1, Abiodun Oluyomi, PhD4*, Omar Rosales, MPH4*, Raka Bandyo, MS5*, Courtney Nicole Miller-Chism, MD1, Mark M. Udden, MD1, Martha P. Mims, MD, PhD1, Tareq Abuasab, MD1*, Akiva Diamond, MD1, Purnima Sravanti Teegavarapu, MD1, Chijioke Nze, MD, MPH6, Christopher R. Flowers, MD, MS6 and Ang Li, MD, MS7

1Section of Hematology-Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX
2Department of Medicine, Baylor College of Medicine, Houston, TX
3Institute for Clinical & Translational Research, Baylor College of Medicine, Houston, TX
4Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, TX
5Harris Health System, Houston, TX
6Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
7Baylor College of Medicine, Houston, TX

Shayna R Sarosiek1, Monika Salkar, PhD2*, Barnabie Agatep, MPH3*, Barton Jones, MS3*, Michelle Pacia, PharmD, MBA2*, Chadi Saifan, MD2*, Shaffee Bacchus, PharmD2*, Sudeep Karve, PhD2* and Jonas Paludo, MD4

1Dana-Farber Cancer Institute, Boston, MA
2AbbVie, North Chicago, IL
3Inovalon, Bowie, MD
4Division of Hematology, Mayo Clinic, Rochester, MN

Brijesh Gautama, MPharm (Hons), MSc, PGDip1*, Nick Duncan, MSc, BPharm2*, Peter Fletcher, MSc3* and Caroline Besley, MBChB, MRCP, FRCPath, PhD4*

1Department of Pharmacy, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom
2Department of Pharmacy, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
3Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom
4Department of Haematology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom

Zhao Peiqi1*, Shu Zhao2*, Chen Huang3*, Jiesong Wang4*, Junqing Xu5*, Lanfang Li1*, Zhengzi Qian1*, Wei Li6*, Shiyong Zhou1*, Lihua Qiu1*, Xianming Liu1*, Ying Chen7*, Yanan Jiang5*, Yanbin Zheng7*, Daoguang Chen8*, Yuhuan Gao, MD3*, Qingyuan Zhang2* and Huilai Zhang, MD1

1Department of Lymphoma, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China
2Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, China
3Department of Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
4FUJIAN CANCER HOSPITAL, Fujian, China
5Department of Hematology, Yantai Yuhuangding Hospital Affiliated to Qingdao University, Yantai, China
6Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, China
7Department of Lymphoma & Head and Neck Oncology, College of Clinical Medicine for Oncology, Fujian Medical University, Fuzhou, China
8Fujian Provincial Cancer Hospital, The Affiliated Tumor Hospital of Fujian Medical University, Fuzhou, China

Dima el-Sharkawi1*, Deborah Rahman2*, Lisa Lowry3*, Jo Kelly4*, Hanna Kew5*, Nimish Shah6*, Daniel Martins4*, Toby Kent4*, Louise Powell4*, Beenish Manzoor7* and Nicolas Martinez-Calle8*

1The Royal Marsden NHS Foundation Trust, London, United Kingdom
2Queen Alexandra Hospital NHS Foundation Trust, Portsmouth, United Kingdom
3Musgrove Park Hospital NHS Foundation Trust, Taunton, United Kingdom
4AbbVie Ltd., Maidenhead, United Kingdom
5AbbVie Ltd, Maidenhead, United Kingdom
6Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, United Kingdom
7AbbVie Inc., North Chicago, IL
8Nottingham University Hospitals NHS Foundation Trust, Nottingham, United Kingdom

Tycel Phillips, MD1*, Mengyang Di, MD, PhD2, Taavy Miller3*, Jingru Wang, BA3*, Amy Pierre, MSN, RN, ANP-BC3*, Gregory A. Maglinte4*, Erlene Kuizon Seymour, MD5 and Yucai Wang, MD, PhD6

1City of Hope, Duarte, CA
2University of Washington, Seattle, WA
3Flatiron Health, New York, NY
4BeiGene USA, Inc, Los Angeles, CA
5BeiGene USA, Inc, San Mateo, CA
6Division of Hematology, Mayo Clinic, Rochester, MN

Alexis Romero1*, Sophia Nguyen, MPH, BS2*, Amy A. Ayers, MPH3*, Minxing Chen, MS2*, Clark R. Andersen, MS2*, Rebecca Yzquierdo2*, Adiya Rahman2*, Lauren Johnson2*, Tiffany Vickers2*, Zeinab Wafi2*, Lorna McNeill, PhD, MPH2*, James R. Cerhan, MD, PhD4, Christopher R. Flowers, MD, MS3 and Chijioke Nze, MD, MPH3

1University of Texas MD Anderson Cancer Center, Mountain View, CA
2University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
4Division of Epidemiology / Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN

Minoo Battiwalla, MD1,2, Shanna Arnold Egloff, PhD, MSCI3*, Betsy Blunk, BSN, RN2*, Casey Martin, MS4*, Meredith Mattlin4*, Katie Culos5*, Hil Hsu, PhD, MPH, BS5*, Timothy Best, PhD6*, Nosha Farhadfar, MD7*, Michael T. Tees, MD, MPH8, Uttam K Rao, MD, MBA9, John Mathews, MD10*, Priya Amin3*, Rocky L. Billups, MS2, Tonya Cox, BSN, RN2 and Navneet Majhail, MD, MS, FASTCT2

1Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center, Nashville, TN
2Sarah Cannon Transplant and Cellular Therapy Network, HCA Healthcare, Nashville, TN
3HCA Healthcare Research Institute, HCA Healthcare, Brentwood, TN
4Genospace, Inc., Boston, MA
5Kite, a Gilead Company, Santa Monica, CA
6Kite Pharma, a Gilead Company, Santa Monica, CA
7Sarah Cannon Transplant and Cellular Therapy Network, HCA Healthcare, San Antonio, TX
8HCA Healthcare, Sarah Cannon Transplant and Cellular Therapy Network, Denver, CO
9Sarah Cannon Transplant and Cellular Therapy Network, HCA Healthcare, Austin, TX
10Sarah Cannon Transplant and Cellular Therapy Network, HCA Healthcare, Dallas, TX

Xu Ji, PhD1, Rebecca Williamson Lewis, MPH2*, Tarun Jain, MD, MSc3, Lu Zhang, PhD4* and Sharon M. Castellino, MD, MSc3

1Department of Pediatrics, Emory University / Children's Healthcare of Atlanta, Atlanta, GA
2Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
3Department of Pediatrics, Division of Hematology, Oncology, and Bone Marrow Transplant, Emory University School of Medicine, Atlanta, GA
4Clemson University, Clemson, SC

Nadia Toumeh, MD1*, Melissa C. Larson, MS2*, Bri J Negaard2*, Carla Casulo, MD3, Sairah Ahmed, MD4, Matthew J. Maurer, DSc2, Andrew L. Feldman, MD5, Brian K. Link, MD6*, Jonathon B. Cohen, MD, MS7, Thomas M. Habermann, MD8, Dai Chihara, MD, PhD9, Izidore S. Lossos, MD10, Jonathan W. Friedberg, MD11, Brad Kahl, MD12*, Peter Martin, MD13, Christopher R. Flowers, MD, MS4, James R. Cerhan, MD, PhD8,14, Annalynn M Williams, PhD, MS15, Allison C. Rosenthal, DO16, Carrie A Thompson, MD, MS8 and Urshila Durani, MD, MPH8

1Internal Medicine, Mayo Clinic Rochester, Rochester, MN
2Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
3Division of Hematology and Medical Oncology, Wilmot Cancer Institute, University of Rochester, Rochester, NY
4Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
6Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
7Winship Cancer Institute, Emory University, Atlanta, GA
8Division of Hematology, Mayo Clinic, Rochester, MN
9Lymphoma and Myeloma, National Institute of Health, Houston, TX
10Division of Hematology, Sylvester Comprehensive Cancer Center, Miami, FL
11Wilmot Cancer Institute, University of Rochester, Rochester, NY
12Division of Oncology, Washington University, St Louis, MO
13Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
14Division of Epidemiology / Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
15University of Rochester Medical Center - James P. Wilmot Cancer Center, Rochester, NY
16Division of Hematology/Oncology Mayo Clinic, Phoenix, AZ

John Sharp, MD1, Subodh Bhatta, PhD2, Noah Takacs3*, Kathleen Tong3*, Youssef Youssef, MD2, David A. Bond, MD, BS4, Yazeed Sawalha, MD4, Audrey M. Sigmund, MD4, Lalit Sehgal, PhD1, Lapo Alinari, MD, Ph.D1, Robert Baiocchi, MD, PhD1, Kami J. Maddocks, MD5, Beth Christian, MD4, Timothy Voorhees, MD, MSc4 and Narendranath Epperla, MD MS6

1James Comprehensive Cancer Center, The Ohio State University, Columbus, OH
2The Ohio State University, Columbus, OH
3The Ohio State University College of Medicine, Columbus, OH
4Division of Hematology, The Ohio State University, Columbus, OH
5The James Cancer Center, The Ohio State University, Columbus, OH
6Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH

Mavis Obeng-Kusi, PhD, MPharm1*, Enrico De Nigris, MSc2*, Siyang Leng, MD, MS1*, Mohammed Z. H. Farooqui, DO1, Halit O. Yapici, MD, MBA, MPH3*, Ian Weimer, MS3*, Weiqi Jiao, ScM3*, Hayden W. Hyatt, PhD3*, Xuan Zhang, MD, PhD, PhD3*, Kunal Lodaya, MD3* and David Dingli, MD, PhD4

1Merck & Co., Inc., Rahway, NJ
2MSD (UK) Limited, London, United Kingdom
3Boston Strategic Partners, Boston, MA
4Division of Hematology, Mayo Clinic, Rochester, MN

Tammarah Sklarz, MD1, Jill S Hasler, PhD2*, Carolyn Y. Fang, PhD3* and Zachary AK Frosch, MD, MSHP4

1Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA
2Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, PA
3Cancer Prevention and Control Research Program, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA
4Department of Hematology/Oncology; Cancer Prevention and Control Research Program, Fox Chase Cancer Center, Philadelphia, PA

Pier Luigi Zinzani, MD1, Lisa Argnani, PhD2*, Martina Cantelli3*, Gabriele Gugliotta, MD4*, Beatrice Casadei, MD5*, Marianna Gentilini, MD3*, Vittorio Stefoni3*, Cinzia Pellegrini6*, Alice Morigi3*, Nicole Fabbri3*, Giulia Gabrielli, MD2*, Camilla Mazzoni, MD7*, Pierluca Maglio3*, Gianmarco Bagnato7* and Alessandro Broccoli, MD, PhD2*

1Department of Medical and Surgical Sciences, Institute of Hematology "L. and A. Seràgnoli", University of Bologna, Bologna, Italy
2Institute of Hematology “L. e A. Seràgnoli”, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
3Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
4IRCCS Azienda Ospedaliero–Universitaria di Bologna, Istituto di Ematologia "Sèragnoli", Italy, Bologna, Italy, Bologna, Italy
5IRCCS Azienda Ospedaliero-Universitaria di Bologna  Istituto di Ematologia “Seràgnoli”, Bologna, Italy
6IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, ITA
7Department of Medical and Surgical Sciences, University of Bologna, Bologna, ITA

Jia Yi Tan, MD1, Yong Hao Yeo, MBBS2*, Hermon Wong Kha Kin, MD3*, Qi Xuan Ang, MBBS4*, Mohammad Muhsin Chisti, MD5 and Daniel Ezekwudo, MD, PhD6

1Department of Internal Medicine, Saint Michael's Medical Center, Newark, NJ
2Department of Internal Medicine/Pediatrics, Corewell Health, Royal Oak, MI
3Universiti Malaysia Sabah, Kota Kinabalu, Malaysia
4Department of Internal Medicine, Sparrow Health System and Michigan State University, East Lansing, MI
5Corewell Health William Beaumont University Hospital, Royal Oak, MI
6Hematology and Oncology, Corewell Health William Beaumont University Hospital, Royal Oak, MI

Mazyar Shadman, MD1*, Lindsey Roeker, MD2, Javier Pinilla-Ibarz, MD, PhD3, Bhavini Srivastava, MSc4*, Sudeep Karve, PhD4*, Gabriel S. Krigsfeld, PhD4*, Erin Franceschini, MS4*, Chadi Saifan, MD4*, Siddharth Karanth, DrPh, MPH5*, Ravi K. Goyal, PhD5*, Julien Rombi, MA5* and Deborah M. Stephens, DO6

1Fred Hutchinson Cancer Center, Seattle, WA
2Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
3Moffitt Cancer Center, Tampa, FL
4AbbVie, North Chicago, IL
5RTI Health Solutions, Durham, NC
6University of North Carolina Chapel Hill, Chapel Hill, NC

Paul A. Hamlin, MD1, Pallawi Torka, MD2, Eric Hansen, MS3*, Andrew J. Belli, MPH3*, Jacob Ambrose, MS3*, Christina M. Zettler, MPH3*, Laura L. Fernandes, PhD3, Stephanie Wiley, RN, OCN3*, Brittney Perry, RN, OCN3* and Ching-Kun Wang, MD3*

1Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Memorial Sloan Kettering Cancer Center, New York, NY
3COTA, Inc., New York, NY

Karla Alexandra Sanchez1*, Katrina Hueniken2*, Solomon Abate3*, Pablo Palomo Rumschisky, MD4*, Carmel Waldron5*, Rachel Aitken6*, Anca Prica, MD7, Michael Crump, MD6*, Vishal Kukreti, MD, MSc8, John Kuruvilla, MD, FRCPC6, Robert Kridel, MD, PhD6, Abi Vijenthira, MD, SM8, Chloe Yang, MD7*, Danielle Rodin, MD, MPH9*, David Hodgson, MD9*, Richard Tsang, MD9*, Nauman Malik9*, Woodrow Wells9*, Christine I Chen, MHPE, MD10 and Sita D. Bhella, MD6

1Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, ON, Canada
2Department of Biostatistics, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
3Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
4Hematology, Hospital Universitario Ramón y Cajal, Madrid, Spain
5Department of Hematology, St James' Hospital, Dublin 8, IRL
6Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
7Princess Margaret Cancer Centre, Toronto, ON, Canada
8Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
9Division of Radiation Oncology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
10Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada

Angela Ramdhanny, MD1, John L Vaughn, MD, MS1 and Narendranath Epperla, MD, MS2

1NYU Grossman Long Island School of Medicine, Mineola, NY
2Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

Alexis Romero1*, Sophia Nguyen, MPH, BS2*, Amy A. Ayers, MPH3*, Rebecca Yzquierdo2*, Lorna McNeill, PhD, MPH2*, Hilary Ma, MD2*, Michael Overman, MD2*, James R. Cerhan, MD, PhD4, Christopher R. Flowers, MD, MS3 and Chijioke Nze, MD, MPH3

1University of Texas MD Anderson Cancer Center, Mountain View, CA
2University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
4Division of Epidemiology / Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN

John Sharp, MD1, Qiuhong Zhao, MS2*, Timothy Voorhees, MD, MSc2, David A. Bond, MD, BS2, Yazeed Sawalha, MD2, John C. Reneau, MD, PhD3, Audrey M. Sigmund, MD2, Walter Hanel, MD, PhD4, Lalit Sehgal, PhD1, Lapo Alinari, MD, Ph.D1, Robert Baiocchi, MD, PhD1, Jonathan E. Brammer2, Kami J. Maddocks, MD5, Beth Christian, MD2, Evandro Bezerra, MD2, Nathan Denlinger, DO, MS2, Sumithira Vasu, MD, MBBS6, Marcos de Lima7*, Jason Prosek8* and Narendranath Epperla, MD, MS9

1James Comprehensive Cancer Center, The Ohio State University, Columbus, OH
2Division of Hematology, The Ohio State University, Columbus, OH
3The James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
4The James Cancer Center, The Ohio State University Wexner Medical Center, Dublin, OH
5The James Cancer Center, The Ohio State University, Columbus, OH
6The Ohio State University Comprehensive Cancer Center, Columbus, OH
7Ohio State University, Columbus, OH
8The Ohio State University, Columbus, OH
9Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH

Carlos Alberto Lopez, MD, MPH1,2, Tyler Franklin Simonek, MS3*, Mosope Folashade Balogun, BSN4*, Kimberly Janelle Noriega, MS5*, Samuel Ogunbode, BS6*, Khadijah Shade Olowu, MSc7*, Cristian Ramirez Rodriguez, BA8*, Angelo Thomas Marra, MPH1* and Leon Bernal-Mizrachi, MD1,2

1Winship Cancer Institute, Emory University, Atlanta, GA
2Georgia Cancer Center for Excellence, Grady Memorial Hospital, Atlanta, GA
3Texas College of Osteopathic Medicine, Fort Worth, TX
4Paul L Foster School of Medicine, El Paso, TX
5University of Toledo College of Medicine and Life Sciences, Toledo, OH
6William Carey University College of Medicine, Hattiesburg, MS
7Southern Illinois University School of Medicine, Springfield, IL
8Touro College of Osteopathic Medicine, New York, NY

Gwynivere A Davies, MD MPH1,2, Anca Prica, MD3,4, Zharmaine Ante5*, Ning Liu, PhD6*, Gregory R Pond, PhD2,7*, Amaris K Balitsky, MD, MSc, FRCPC2,8 and Lee Mozessohn, MD3,9

1Department of Oncology, Juravinski Cancer Centre (HHSC), McMaster University, Hamilton, ON, Canada
2Escarpment Cancer Research Institute, Hamilton, Canada
3Department of Medicine, University of Toronto, Toronto, ON, Canada
4Divison of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
5Research & Analysis, ICES, Toronto, ON, Canada
6ICES, Toronto, ON, Canada
7Department of Oncology, McMaster University, Hamilton, Canada
8Juravinski Cancer Centre, Department of Oncology, McMaster University, Hamilton, Canada
9Sunnybrook Health Sciences Centre, Toronto, ON, Canada

Rahela Aziz-Bose, MD1,2,3,4, Morgan A. Paul, MS5*, Yael Flamand, MS5*, Colleen A. Kelly, MD1,2, Leanne Duhaney, MD, MPH6*, Puja J. Umaretiya, MD, MS7*, Lucille Lokko, BA1*, McKenzie Griffin, BS1*, Alexandria Hawkins, BS1*, Peter D. Cole, MD8, Lisa M. Gennarini, MD9*, Justine M. Kahn, MD, MSc10, Kara M. Kelly, MD11, Victoria B. Koch, BS1*, Bruno Michon, MD, FRCPC12*, Thai Hoa Tran, MD13, Jennifer J.G. Welch, MD14, Lewis B. Silverman, MD15 and Kira Bona, MD, MPH1,2,3,4

1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
2Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA
3Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA
4Department of Pediatrics, Harvard Medical School, Boston, MA
5Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
6Department of Cardiology, Boston Children's Hospital, Boston, MA
7Division of Pediatric Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, TX
8Division of Pediatric Hematology/Oncology, Rutgers Cancer Institute, New Brunswick, NJ
9Division of Pediatric Hematology/Oncology and Blood & Marrow Cell Transplant, Montefiore Medical Center, Bronx, NY
10Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Columbia University Irving Medical Center, New York, NY
11Department of Pediatric Oncology, Roswell Park Comprehensive Cancer Center, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY
12Division of Hematology-Oncology, Centre Hospitalier Universitaire De Québec, Québec City, QC, Canada
13Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, CHU Sainte-Justine, Montreal, QC, Canada
14Division of Pediatric Hematology and Oncology, Hasbro Children’s Hospital, Warren Alpert Medical School of Brown University, Providence, RI
15Division of Pediatric Hematology/Oncology, Columbia University Irving Medical Center, New York, NY

Frederique St-Pierre, MD1, Subodh Bhatta, PHD2, Peter Doukas, MD3*, Madeline A. Jenkin, BS4*, Kaitlin Annunzio, DO5, Alexandra E. Rojek, MD6, Yun Kyoung Tiger, MD, PhD7, Brittany McCall, MD8*, Khaled Alhamad, MD9*, Alec Hansen10*, Juan Pablo Alderuccio, MD11, Olutobi Adewale, MD12*, Keem Patel, MD12*, Asaad Trabolsi, MD13, Izidore S. Lossos, MD14, Lindsey Fitzgerald, MD15, Thomas Ollila, MD16, Matthew Matasar, MD, MS17, Justin Kline, MD18, Reem Karmali, MD19 and Narendranath Epperla, MD, MS9

1Department of Hematology/Oncology, Great River Health/Southeast Iowa Regional Medical Center, Burlington, IA
2Department of Medicine, Division of Hematology, The Ohio State University, Columbus, OH
3Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
4Northwestern University Feinberg School of Medicine, Chicago
5The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
6Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
7Division of Hematology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
8Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI
9Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
10Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT
11Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
12Department of Hematology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
13University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
14Division of Hematology, Sylvester Comprehensive Cancer Center, Miami, FL
15Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
16Lifespan Cancer Institute, Rhode Island Hospital, Providence, RI
17Division of Blood Disorders, Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, New York, NY
18University of Chicago, Chicago, IL
19Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL

Xavier Deschênes-Simard, MD, PhD1,2,3*, Maria Bromberg, MPH4*, Sean M. Devlin, PhD4*, Ofrat Beyar Katz5,6, Andrew Ip, MD, MSc7,8, Ronit Marcus, MD9,10*, Abraham Avigdor, MD10,11, Annamaria Ballweg, MD12*, Emma Rabinovich, MD13,14, Mohammad Alhomoud, MD15, Alfredo Rivas-Delgado, MD, PhD16, Magdalena Corona, MD, PhD3*, Alejandro Luna De Abia, MD, PhD15,17*, Maria Lia Palomba, MD18,19, Gunjan L. Shah, MD20,21,22, Richard J. Lin, MD, PhD20,21,22, Alexander P. Boardman, MD16,21,22*, Lorenzo Falchi, MD18,21,22, Jennifer Kimberly Lue, MD18,22, Gilles Salles, MD, PhD18,19,21, Miguel-Angel Perales, MD20,21,23, Roni Shouval, MD, PhD15,21,23, Parastoo B Dahi, MD20,21,22* and Michael Scordo, MD21,22,24

1Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY
2Department of Medicine, University of Montreal, Montréal, QC, Canada
3Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY
4Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Hematology and BMT, Rambam Health Care Campus, Haifa, Israel
6The Ruth and Bruce Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel
7Hackensack Meridian School of Medicine, Hackensack, NJ
8Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
9School of Medicine, Faculty of Medical and health Sciences,Aviv University, Tel Aviv, Israel
10Division of Hematology & Bone marrow transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel, School of Medicine, Tel-Aviv University, Tel Aviv, Israel
11School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel Aviv, Israel
12Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York
13Department of Bone Marrow Transplant, Memorial Sloan Kettering Cancer Center, New York, NY
14Rutgers Cancer Institute, Robert Wood Johnson Barnabas, New Brunswick, NJ
15Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
16Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY
17Unidad de trasplante y terapia celular, Hospital Universitario Ramon y Cajal, Madrid, Spain
18Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
19Department of Medicine, Weill Cornell Medical College, New York
20Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
21Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
22Department of Medicine, Weill Cornell Medical College, New York, NY
23Department of Medicine, Weill Cornell Medicine, New York, NY
24Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY

Amaris K Balitsky, MD, MSc, FRCPC1,2,3, Gregory R Pond, PhD1,2*, Hira Mian, MD2,3,4, Gwynivere A Davies, MD MPH2,5,6, Ronan Foley, MD, FRCPC1,3*, Graeme Andrew McCrae Fraser, MD, MSc, FRCPC6,7, Jonathan Sussman, MD, MSc, FRCPC1* and C. Tom Kouroukis, MD, MSc, FRCPC1,3

1Department of Oncology, McMaster University, Hamilton, Canada
2Escarpment Cancer Research Institute, Hamilton, Canada
3Juravinski Cancer Centre, Hamilton Health Sciences, Hamilton, Canada
4McMaster University, Hamilton, ON, Canada
5Department of Oncology, Juravinski Cancer Centre (HHSC), McMaster University, Hamilton, ON, Canada
6Juravinski Hospital and Cancer Center, Hamilton Health Sciences, Hamilton, ON, Canada
7Department of Oncology, McMaster University, Hamilton, ON, Canada

Syeda A Mina, MBBS1, Katherine E Smith, MD1*, Ashley D Hickman, MD1*, Melissa C. Larson, MS2*, Brianna J Negaard, MS2*, Brittany C Kimball, MD1, Matthew J. Maurer, DSc2*, Kathleen J Yost, PhD2*, Grzegorz S. Nowakowski, MD3, Izidore S. Lossos, MD4, Peter Martin, MD5, Jonathon B. Cohen, MD, MS6, Brian K. Link, MD7*, Brad S. Kahl, MD8, Loretta Nastoupil9*, James R. Cerhan, MD, PhD1, Christopher R. Flowers, MD, MS10, Amylou C Dueck, PhD11, Annalynn M Williams, PhD, MS12, Carla Casulo, MD12, Carrie A Thompson, MD, MS1 and Urshila Durani, MD, MPH1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
3Mayo Clinic, Rochester, MN
4Division of Hematology, Sylvester Comprehensive Cancer Center, Miami, FL
5Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
6Winship Cancer Institute, Emory University, Atlanta, GA
7Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
8Washington University School of Medicine, Saint Louis, MO
9Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
10Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX
11Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ
12University of Rochester Medical Center - James P. Wilmot Cancer Center, Rochester, NY

Hasmukh Jain, MD, DM1*, Atharva Karulkar2*, Devanshi Kalra2*, Smrithi Ravikumar2*, Shreshtha Shah2*, Afrin Firfiray2*, Juber Pendhari2*, Manivasagam S2*, Anand Vaibhaw2*, Ashish Saroha, PhD2*, Ankesh K. Jaiswal3*, Alok Shetty, MD, DM4*, Lingaraj Nayak, MBBS, MD, DM4*, Bhausaheb Bagal, MD, DM5*, Neeraj Siddharthan, DNB DM6*, Esha Kaul, MD7*, Prashant Mehta, MD, MBBS, DM8, Anshul Gupta, MD9, Navin Khattry, MD, DM5*, Nishant Jindal, MD, DM5*, Sanket P Shah, MD, DM10*, Rakesh Kumar Boya11*, Pavan Kumar Boyella, MD12*, Preeti Desai, MD13*, Anisha Navkudkar, MD13*, Shalini Purwar2*, Manju Sengar, MD, DM1, Nirali N. Shah, MD14, Sattva S. Neelapu, MD15 and Rahul Purwar, PhD2,3*

1Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India
2Immunoadoptive Cell Therapy Private Limited (ImmunoACT), Mumbai, India
3Department of Biosciences and Bioengineering, Indian Institute of Technology, Bombay, Mumbai, India
4Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
5Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India
6Amrita Institute of Medical Sciences, Kochi, India
7Max Super Speciality Hospital, Vaishali, Delhi, India
8Amrita Institute of Medical Sciences, Faridabad, India
9Medanta Super Speciality Hospital, Lucknow, India
10Hemato Oncology Clinic, Vedanta, Ahmedabad, India
11Apollo Hospitals, Visakhapatnam, India
12Basavatarakam Indo American Cancer Hospital, Hyderabad, India
13Department of Transfusion Medicine, Tata Memorial Centre, Mumbai, India
14Pediatric Oncology Branch, NIH, Bethesda, MD
15Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

James H Essell, MD1, Benjamin A Derman, MD2, Michael A. Kolodziej, MD3*, Lavi Kwiatkowsky3*, Geoffrey Calkins3*, Christina M Parrinello, PhD, MPH4* and Mustafa S Ascha, PhD3*

1Oncology/Hematology Care, Cincinnati, OH
2Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL
3Canopy Care, New York City, NY
4Pine Mountain Consulting, New York City

Maria Queralt Salas, MD1*, Pilar Ayora2*, Carla Ramos3*, Nuria Martinez-Cibrian4*, Nil Albiol, MD2*, Carola Diaz Aizpun, MD5*, Beatriz Herruzo, MD6*, Sara Fernandez-Luis, MD7*, Leddy Patricia Vega Suárez7*, Zahra Abdallahi Lefdil8*, Veronica Illana Álvaro8*, María del Carmen Quintela González9*, Ana Santamaria, MD9*, Andres Sanchez Salinas, MD10*, Ana Alarcón Tomás11*, Alberto Mussetti, MD12*, Silvia Filafferro13*, Pascual Balsalobre14*, Angel Cedillo15* and Ana Maria Sureda Balari, MD, PhD16

1Hematopoietic Transplantation Unit, Hospital Clinic de Barcelona, ICAMS, Barcelona, Spain
2Hematology Department, Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain, Barcelona, Spain
3Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain, Barcelona, Spain
4Hospital Clínic de Barcelona, Barcelona, Spain
5Hospital Regional Universitario de Málaga, Málaga, Spain
6Hospital Regional Universitario de Málaga, Malaga, Spain
7Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
8Hospital Universitario de la Princesa, Madrid, Spain
9Hospital Álvaro Cunqueiro, Vigo, Spain
10Hematology Department, Hospital Universitario Virgen de la Arrixaca., Murcia, Spain
11Hematology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Spain
12Clinical Hematology Department, Institut Catala d’Oncologia-Hospitalet, L'Hospitalet De Llobregat, Barcelona, Spain
13Grupo EspañOl De Trasplante De Progenitores HematopoyéTicos Y Tera, Madrid, ESP
14Grupo Español de Trasplante de Progenitores Hematopoyéticos y Terapia Celular (GETH-TC) Data Office, Madrid, Spain
15GETH Data Office, Madrid, Spain
16Clinical Hematology Department, Institut Català d’Oncologia-Hospitalet, IDIBELL, Barcelona, Spain

Swamroop V Nandwani1*, Alexander J. Didier1, Alan Fahoury1* and Divya Vijendra, MD2*

1University of Toledo College of Medicine and Life Sciences, Toledo, OH
2Department of Hematology/Oncology, University of Toledo College of Medicine and Life Sciences, Toledo

*signifies non-member of ASH